Editorial: is functional cure the only holy grail for treatment discontinuation in patients with HBeAg-negative chronic hepatitis B?

Aliment Pharmacol Ther. 2022 Aug;56(3):544-545. doi: 10.1111/apt.17067.

Authors

Yen-Chun Liu^{1

2}, Wen-Juei Jeng^{1

2}

Affiliations

¹ College of Medicine, Chang Gung University, Taipei, Taiwan.
² Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

PMID: 35804472
DOI: 10.1111/apt.17067

No abstract available

Publication types

Editorial
Comment

MeSH terms

Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis B virus
Hepatitis B, Chronic* / drug therapy
Humans

Substances

Hepatitis B Surface Antigens
Hepatitis B e Antigens